TY -的T1 -直接口服抗凝血剂treatment of acute venous thromboembolism in patients with cancer: a meta-analysis of randomised controlled trials JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.01097-2017 VL - 50 IS - 3 SP - 1701097 AU - Di Minno, Matteo Nicola Dario AU - Ageno, Walter AU - Lupoli, Roberta AU - Conte, Giulia AU - van Es, Nick AU - Buller, Harry R. AU - Dentali, Francesco Y1 - 2017/09/01 UR - //www.qdcxjkg.com/content/50/3/1701097.abstract N2 - Venous thromboembolism (VTE) is a common complication in cancer patients [1, 2], associated with an 8–10% annual bleeding risk during anticoagulant therapy and a 10–20% annual risk of VTE recurrence [1, 3].DOACs have a marginally higher antithrombotic efficacy and a comparable safety than VKA in cancer patients with VTE http://ow.ly/5lJN30dVVGFAuthor contributions: M.N.D. Di Minno conceived and designed the study, performed the analysis, interpreted results and drafted the manuscript; F. Dentali conceived and designed the study, and performed literature searches, data extraction and manuscript drafting; R. Lupoli and G. Conte performed literature searches, data extraction and manuscript drafting; N. van Es, H. Büller and W. Ageno interpreted results and performed critical revision of the manuscript. All authors read and approved the final version of the manuscript. ER -